September 19th 2025.
At the start of the session, the Nifty index had a strong opening with a gap-up of almost 100 points, reaching 25441. It then traded within a narrow 40-point range in the first half. As the day progressed, there were attempts by the bears to bring the index down to the 25350 level, but the bulls made a comeback in the final half hour, pushing the prices back towards the opening high of the day. Despite some ups and downs during the day, the overall sentiment remained positive, with the "buy-on-dips" strategy still in play. Looking at the daily chart, it is evident that the Nifty formed a small-bodied candle with a longer lower shadow, indicating strong buying interest near support levels. The index ended the day with gains of around 90 points and has been consistently forming higher lows for the past seven sessions, reinforcing the positive undertone. In order to continue this upward trend, the index needs to maintain its hold above the 25350 level, with potential targets at 25550 and 25700. The support levels have also shifted higher to 25350 and 25200.
On the options front, the Maximum Call OI is at 25500 and 25400 strike, while the Maximum Put OI is at 25400 and 25300 strike. There is significant Call writing at 25400 and 25500 strike, while Put writing is seen at 25400 and 25450 strike. This suggests a broader trading range between 24900 and 25900, with an immediate range between 25200 and 25700.
The Sensex also had a positive opening and traded within a narrow 200-point range in the early part of the session. There was some profit booking from higher levels, but in the final hour, the index rebounded from the support of 82700, climbing back towards the 83000 mark. On the daily chart, the Sensex formed a small-bodied candle with a long lower shadow, indicating renewed buying interest at lower levels. The index closed the day with modest gains of around 320 points, closing above the 83000 level. In order to continue the upward trend, the Sensex needs to maintain its hold above the 82700 level, with potential targets at 83400 and 83700. The support levels have also shifted higher to 82700 and 82500.
The Bank Nifty index had a strong opening near 55800, but then traded within a narrow 150-point range in the first half of the session. Later on, it failed to hold on to the higher levels and drifted lower towards 55500, before making a good recovery in the latter part of the session. It eventually formed a small bearish candle on the daily scale with a long lower shadow, indicating buying interest at lower levels and forming higher lows for the past nine sessions. To continue this upward trend, the index needs to hold above the 55500 level, with potential targets at 56000 and 56250. On the downside, support is seen at 55500 and 55250.
In the futures market, the Nifty closed with a gain of 0.34% at 25510 levels. The day saw positive movement in Glenmark, Biocon, Mankind, Laurus Lab, Aurobindo Pharma, LTI Mindtree, AB Capital, Kfin Technologies, LTF and Eternal, while there was weakness seen in Kalyan Jewellers, PI industries, Coal India, Solar Industries, Inox Wind, Cyient, Titan, Trent, Oil India, BSE and United Spirits.
Shares of Glenmark Pharmaceuticals jumped 10% after announcing a deal with AbbVie, worth USD 2 billion, to commercialize a new drug for cancer and autoimmune diseases. This positive news is expected to lead the next surge in the market.
Moving on to some stock-specific news, Allied Blenders' super-premium and luxury spirits subsidiary, ABD Maestro Pvt. Ltd., announced its debut in the Duty-Free Travel Retail at Kempegowda International Airport, Bengaluru. This marks the entry of ABD Maestro into the country's Airport Duty Free Travel Retail business, with plans to expand to Delhi International Airport and Mumbai. This expansion reflects the company's confidence and ambition to place their products alongside the world's finest.
Arfin India has secured a significant order from its distributor, JFE Shoji India Pvt Ltd, for the local supply of Aluminium Ingots, Aluminium Wire Rods, and Aluminium Cubes/Shots. This order, valued at approximately Rs 180 crore, will be executed over a period of six months from October 2025 to March 2026. This further strengthens the company's domestic and international presence and reflects the trust and long-term relationship with its distributor.
Metropolis Healthcare announced the completion of its fourth acquisition in the last 10 months, with the addition of Dr. R.S. Patil's Ambika Pathology Laboratory in Kolhapur to its network. This NABL-accredited facility will be developed into a mini regional reference lab, offering advanced and specialty diagnostics to patients in Kolhapur and neighboring Tier-2 and Tier-3 towns.
Texmaco Rail & Engineering Ltd has been awarded an order of Rs 86.85 crore from M/s. Ultratech Cement Limited for BCFC Wagons along with Brake Van, to be delivered by March 2026.
CSC E-Governance Services India has crossed the milestone of ₹3,000 crore in loan disbursals, providing a boost to rural households and small businesses.
Ceigall India's Board at its meeting on September 18th has approved the lending of Rs 50 crore as convertible loan in the form of Inter-Corporate Deposit to CCCL. The company will also acquire equity shares of CCCL, as approved by the Hon'ble NCLT. This will eventually lead to Ceigall holding up to 94% of the shareholding in C & C Construction Limited, which will then be reduced to 75% over time.
[This article has been trending online recently and has been generated with AI. Your feed is customized.]
[Generative AI is experimental.]
